Back to resourcesResources

AI Preview vs. Photo Documentation: What's the Difference

TouchMD and RxPhoto document real results after treatment. An AI preview predicts a likely result first. How the two jobs differ and work together.

General information about consult-room technology, not legal, regulatory, or clinical advice.

Put two vendor pages side by side and they can read like the same product. Both say "before and after." Both show a face on a tablet. One is a photo-documentation platform: it stores and organizes the real photos a practice takes of its own patients, before treatment and after. The other is an AI preview: it takes a selfie today and renders a photoreal, illustrative version of a possible after, on that patient's own face, before anything has been done. Both are real technology. They are not the same kind of technology, and a practice choosing between them, or deciding to run both, should know exactly where the line sits.

This distinction matters more than it used to, because consult-room technology is no longer optional. AAFPRS's 2025 member survey found that non-invasive treatments now account for roughly 80 percent of all facial plastic procedures, and more than half of AAFPRS members report that virtual consultations and digital follow-up options are on the rise (aafprs.org). More patients, more screens, more tools in the room. The question isn't whether to use technology in a consult — it's which job each piece of it is actually doing.

Two Different Jobs: Predicting and Documenting

Strip away the branding and every tool in this category does one of two things.

Documentation tools capture, store, and compare real photos of real patients — almost always after a treatment has happened, sometimes as a baseline before it. Their job is accuracy and consistency: same lighting, same angle, same framing, so a "before" and an "after" can be compared honestly. The photo is real. The patient is real. The result already exists.

Predictive preview tools generate an illustrative image of what a specific, prospective patient's own face might look like after a treatment they haven't had yet. The input is a selfie taken today; the output is a simulation, not a record. Nothing in the frame has actually happened.

Neither job is more important than the other, and a practice doesn't have to choose — most eventually run both, at different points in the same patient's journey. But they answer different questions. A documentation tool answers "what did this look like." A predictive preview answers "what might this look like, on me." Confusing them in a buying decision usually means overpaying for a feature you don't need, or missing one you do.

What Tools Like TouchMD and RxPhoto Are Built For

Both of the category's established platforms are, by their own description, documentation and communication tools — not predictive ones.

TouchMD

TouchMD describes itself as "the aesthetic industry's only all-in-one patient education and communication platform" (touchmd.com/medspa). Its component pieces span the full visit: a consult module for patient education, digital consent forms, a telehealth option (Reach), automated patient marketing (Blast), point-of-care screens (Playlist), and a free patient app (myTouchMD) where patients can revisit their consult and view before/after images later. The photography piece, Snap, is built for "beautiful, consistent clinical photography," with "built-in image overlay, gridlines, and levels" so a provider can line up a patient's actual pre- and post-treatment photos for an accurate side-by-side (touchmd.com/snap). One clinician testimonial on the page describes the workflow directly: "You can show a patient their pre-injection photos and bring them back after they've had injections so they can really see and evaluate their results." That's the job — comparing two real moments in time, not forecasting a third.

RxPhoto

RxPhoto is more narrowly scoped, and says so plainly: "The before-and-after photo solution built for aesthetic practices" (rxphoto.com). It offers guided capture with on-screen positioning, "ghosting overlays for perfect 'after' alignment," HIPAA-compliant storage the company says now holds more than 80 million before-and-after photos, and galleries that auto-sync to a practice website or consult view. RxPhoto's own site cites a stat worth noting for anyone building a consult-room strategy: "74.8% of consumers won't consider a practice without a before & after gallery." One practice's testimonial on the same page describes going "from closing 45% of our consultations to over 90%" after adopting the platform — a single customer's reported result, not an industry average, but a useful signal of how much a strong real-photo gallery can move a consult forward.

Both platforms handle something the industry doesn't always treat with enough care: the photos themselves are protected health information the moment they're tied to a patient's identity and treatment record, cash-pay or not (americanmedspa.org) — a fuller walkthrough of that obligation is in our HIPAA checklist for before-and-after photos. Neither TouchMD nor RxPhoto publishes pricing; both are enterprise sales motions reached through a demo or quote.

What a Predictive AI Preview Adds

None of the above tells a prospective patient what they're actually curious about before they book: what might this look like on my face. That's the gap a predictive preview like AfterVue is built to close, and the scale of demand behind it is not small. ASPS's 2025 statistics report found that neuromodulators and hyaluronic fillers together accounted for 80 percent of all minimally invasive procedures performed that year, with overall cosmetic surgical volume up 7 percent (plasticsurgery.org). Globally, ISAPS's 2024 Global Survey counted roughly 20.5 million non-surgical procedures, including 7.8 million botulinum toxin treatments and 6.3 million hyaluronic acid filler procedures (isaps.org). That's an enormous number of consult-room conversations happening about a result the patient has never seen on their own face.

Predictive imaging in aesthetic consultations isn't new, and the research on it is worth taking seriously precisely because it doesn't oversell what a preview can do. A study of computer-imaged rhinoplasty patients, published in the Archives of Facial Plastic Surgery, found patients rated the accuracy of their preoperative computer images at 3.4 out of 5, while the expert panel scored the images 3 out of 5, which the researchers described as moderately accurate rather than exact — while still finding the process genuinely useful for understanding the surgeon's aesthetic and building trust ahead of surgery (sciencedaily.com). That's the honest case for a preview tool: it's a communication aid that gives a shared starting point for a conversation, not a promise of the exact outcome. It's also why AfterVue labels every preview an illustrative simulation, not a clinical guarantee — the research backs that framing rather than undercutting it.

AfterVue's preview works from a single selfie: a patient sees a photoreal, illustrative preview of their own likely result for Botox, filler, lips, under-eyes, or skin, with no beauty score attached — a deliberate choice explained further in why AfterVue doesn't rate faces. The photo itself is never stored. When the patient is ready, they're sent to the practice's own booking link; AfterVue doesn't run the booking flow itself and doesn't do clinical follow-up — its job stops at the preview and the handoff, by design. AAFPRS's own members reflect a similarly measured stance toward AI in the consult room, noting that surgeons "remain focused on adopting tools that genuinely enhance communication, personalization, and the patient experience, without replacing clinical judgment or expertise" (aafprs.org) — which is exactly the lane a predictive preview is meant to occupy: alongside clinical judgment, never in place of it.

Using Both Together

Most practices don't end up choosing one category over the other — they run a documentation platform for the clinical record and marketing gallery, and add a predictive preview earlier in the journey, before that record even exists. The table below lays out where each one actually sits.

Photo documentation (TouchMD, RxPhoto) Predictive AI preview (AfterVue)
Question it answers What did this patient's result actually look like? What might my result look like, on my own face?
When it's used At treatment visits, before and after Before booking — on the website or at consult start
Whose photo The treated patient's real photo The prospective patient's own selfie
What's produced A real, comparable before/after record An illustrative, labeled simulation
Where the photo lives Stored long-term in a HIPAA-eligible platform Never stored — used to generate the preview, then discarded
What happens next Filed to the chart; optionally added to a marketing gallery Patient is sent to the practice's own booking link

Questions to Ask Before You Buy Either

A short list to run through before signing anything, whether it's a documentation platform, a preview app, or both:

  • Is this tool predicting a result the patient hasn't experienced yet, or documenting one that already happened? Sales pages don't always make this obvious.
  • Where do patient photos live once they're captured, and will the vendor sign a Business Associate Agreement?
  • Does the output carry a clear, honest label — "illustrative" or "actual result" — that your front desk and injectors can explain the same way every time?
  • Does the tool try to book the consult itself, or does it hand the patient off to the booking flow you already control?
  • Does it fit next to what you're already running, or does adopting it mean ripping out a system your staff has learned?

None of these questions have a universally right answer — they just make sure the tool you're evaluating is doing the job you actually need, at the point in the visit where you need it.

Where This Leaves Your Consult Room

A photo gallery and a predictive preview aren't competing for the same job. One proves what your practice has already done; the other lets a prospective patient see themselves in the result before they decide to become a patient at all. Practices that treat them as two tools for two moments — rather than trying to make one do both jobs — tend to get more out of each.

If your practice already has a documentation platform in place and is looking at what comes before it, AfterVue is built specifically for that earlier moment: a photoreal, illustrative preview on the patient's own face, with no beauty score and no photo left behind. It sits alongside the rest of your consult-room stack rather than replacing it, and it's built to run next to whatever you're already using. Try the app yourself, or book a live demo to see it next to your current tools.

Frequently Asked Questions

Do I have to replace TouchMD or RxPhoto to add an AI preview app? No. TouchMD and RxPhoto document real photos of patients who have already been treated — that record still needs a compliant home. AfterVue does a different job earlier in the visit: it generates an illustrative preview of a prospective patient's own likely result before they've committed to anything. Most practices that add AfterVue keep their existing documentation platform for clinical photos and use AfterVue on the website or at the start of the consult, not as a replacement.

Is an AI before-and-after preview the same thing as a before-and-after photo gallery? No. A gallery shows real photos of real patients who already had the procedure — useful social proof, but not that visitor's own face. An AI preview like AfterVue's takes the current visitor's own selfie and generates a photoreal, illustrative simulation of their own possible result. One documents what happened to someone else; the other previews what might happen to the person looking at the screen.

Is a predictive AI preview regulated as a medical device? The FDA has adopted the International Medical Device Regulators Forum definition of Software as a Medical Device (SaMD): software intended to be used for one or more medical purposes, performing those purposes without being part of a hardware device. AfterVue's preview is built and labeled as an illustrative simulation, not a diagnostic or treatment tool, and it does not analyze images to recommend or determine a course of treatment. This is general information, not a regulatory or legal determination for your practice — confirm your own obligations with counsel or a regulatory advisor before making claims about any specific product.

Sources

See it on your own face.

Book a live demo to see the AfterVue preview next to your existing consult tools

Questions practices ask

Do I have to replace TouchMD or RxPhoto to add an AI preview app?

No. TouchMD and RxPhoto document real photos of patients who have already been treated — that record still needs a compliant home. AfterVue does a different job earlier in the visit: it generates an illustrative preview of a prospective patient's own likely result before they've committed to anything. Most practices that add AfterVue keep their existing documentation platform for clinical photos and use AfterVue on the website or at the start of the consult, not as a replacement.

Is an AI before-and-after preview the same thing as a before-and-after photo gallery?

No. A gallery shows real photos of real patients who already had the procedure — useful social proof, but not that visitor's own face. An AI preview like AfterVue's takes the current visitor's own selfie and generates a photoreal, illustrative simulation of their own possible result. One documents what happened to someone else; the other previews what might happen to the person looking at the screen.

Is a predictive AI preview regulated as a medical device?

The FDA has adopted the International Medical Device Regulators Forum definition of Software as a Medical Device (SaMD): software intended to be used for one or more medical purposes, performing those purposes without being part of a hardware device. AfterVue's preview is built and labeled as an illustrative simulation, not a diagnostic or treatment tool, and it does not analyze images to recommend or determine a course of treatment. This is general information, not a regulatory or legal determination for your practice — confirm your own obligations with counsel or a regulatory advisor before making claims about any specific product.